При това проучване, 87% от пациентките са имали IHC 3+ заболяване и 95% от включените пациентки са имали IHC 3+ и/ или FISH позитивно заболяване.
In this trial, 87% of patients had disease that was IHC 3+, and 95% of patients entered had disease that was IHC 3+ and/ or FISH positive.